New evidence
A systematic review found Lactobacillus rhamnosus TOM 22.8 at 10×10⁹ CFU/day for 10 days significantly reduced bacterial vaginosis recurrence — but only one strain had strong data, and the optimal dose is still unclear.
This is among the first indexed reviews on this exact strain-dosing combination, so while the result is promising for recurrence prevention, it's a single early signal — not a settled recommendation.
The review identified that among several probiotics tested, L. rhamnosus TOM 22.8 at a specific daily dose for ten days consistently improved vaginal health markers (lower Nugent scores, healthier pH) and cut the chance of bacterial vaginosis coming back. But because the review highlighted only one standout strain and noted the need for better standardized trials, the broader evidence remains too thin to generalize to all probiotics or people.
Where this fits in the evidence
This is among the first studies we've indexed on Lactobacillus jensenii LBV 116 for Reduced Recurrence of Bacterial Vaginosis — treat it as an early signal until more research accumulates.
The study
- Systematic Review
- 2025-03-10
- Narra J
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.